Filter
934
Filtered Results: 934
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
78
New Publications
286
Language
Document type
No document type
482
Studies & Reports
169
Guidelines
140
Manuals
56
Strategic & Response Plan
51
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
39
India
32
Uganda
27
South Africa
24
Global
22
Liberia
21
Ghana
19
Nigeria
19
Rwanda
18
Tanzania
17
Sierra Leone
16
Zambia
16
Malawi
15
Bangladesh
15
Nepal
14
Western and Central Europe
14
Namibia
13
Ukraine
11
Zimbabwe
10
Syria
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
Africa
7
South–East Asia Region
6
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Latin America and the Carribbean
4
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
416
Clinical Guidelines
58
Public Health
36
Key Resources
30
Pharmacy & Technologies
28
Women & Child Health
23
Capacity Building
4
Toolboxes
AMR
123
Pharmacy
118
COVID-19
54
HIV
39
TB
39
Rapid Response
34
Mental Health
32
Global Health Education
20
Planetary Health
19
Caregiver
14
Conflict
14
Ebola
13
Specific Hazards
10
NCDs
10
NTDs
9
Health Financing Toolbox
9
Polio
5
Refugee
2
Natural Hazards
2
Disability
2
Zika
2
Social Ethics
1
Technical Update
HIV Treatment
July 2017
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Malawi Internationally recommended key policies uptake
Building on Nigeria’s Call to Action to Save Newborn Lives, the Federal Ministry of Health (FMoH) has developed the National Strategy and Implementation Plan for Scale-up of Chlorhexidine. The Ministry incorporated existing maternal, newborn, and child health plans with additional comprehensive st...
Interim policy guidance
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs and measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community sy...
